Detection of human myeloid progenitor cells in a murine background.
Cell-mixing experiments were performed to determine whether human (hu) peripheral blood plasma would select for the growth of hu myeloid progenitor cells in vitro. Mixtures of hu male umbilical cord blood and murine (mu) female bone marrow (100% hu, 100% mu, 1.0% hu or 10% hu and 50% hu) were plated in methylcellulose cultures that contained either hu plasma or fetal bovine serum (FBS). Cultures were supplemented with recombinant (r) hu erythropoietin (Epo) alone or in combination with rhu granulocyte-macrophage colony stimulating factor (GM-CSF), rmuGM-CSF or rhu steel factor (SLF). DNA was extracted from day 14 colonies and clusters, and the polymerase chain reaction (PCR) was used to detect the hu Y-chromosome satellite DNA sequence. Results of these studies revealed that hu plasma used in combination with hu growth factors selected for the growth of hu progenitor cells. Mu cells grew in hu plasma only at high cell-plating concentrations. This selective effect was due to a heat labile factor or factors, since mu cells grew equally well in heat-inactivated hu plasma and FBS. Cells in individual progenitor cell colonies and clusters cultured in hu plasma contained hu Y-chromosome-specific DNA sequences that were detectable after PCR-mediated amplification, thus eliminating the need for time-consuming Southern transfer. This study describes a method whereby hu/immune-deficient mice can be screened rapidly for hu myeloid engraftment. These results also indicate that the hu identity of colonies and clusters cultured in hu plasma must be genetically confirmed, especially when hu cells may represent a low percentage of the total cells plated.
Carow
C E
CE
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis 46202-5121.
Harrington
M A
MA
Broxmeyer
H E
HE
D000818:Animals; D001483:Base Sequence; D001854:Bone Marrow Cells; D002478:Cells, Cultured; D004247:DNA / Q000032:analysis / Q000737:chemistry; D004921:Erythropoietin / Q000494:pharmacology; D005260:Female; D005312:Fetal Blood / Q000166:cytology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000494:pharmacology; D006098:Granulocytes / Q000737:chemistry / Q000166:cytology*; D016298:Hematopoietic Cell Growth Factors / Q000494:pharmacology; D006412:Hematopoietic Stem Cells / Q000737:chemistry / Q000166:cytology*; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins / Q000494:pharmacology; D019089:Stem Cell Factor; D014998:Y Chromosome
D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins; D019089:Stem Cell Factor; D004921:Erythropoietin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D004247:DNA